World

Home / World / Americas

Alzheimer's drug shows promise in early results of study

China Daily Global | Updated: 2022-09-29 09:29

Share - WeChat

Japan's pharmaceutical company Eisai and US biotech company Biogen said on Tuesday that their joint Alzheimer's treatment, which appeared to slow the fatal disease in a late-stage study, has been submitted to the US Food and Drug Administration for accelerated approval.

Photos

First high-speed train set to connect Las Vegas, LA

Kung fu coach furthers his dream in Kenyan hometown

2 feared dead after cargo plane crashes in Alaska

Pro-Palestinian protests spread to campuses

Beijing hopes Blinken visit to boost dialogue

Solomon Islands PM's party wins most seats in parliamentary election: report

Most Viewed in 24 Hours

Special Coverage +

Terrorist attack at Moscow concert

My China Album

World in photos

The world in photos: April 15 – 21

Newsmakers +

Sherry's melody: eight years of singing in Belgium

Sichuan woman cycles 2,400 km to learn Thai martial art

China-Japan +

Promotion of Sino-Japanese dialogue sought

China-US +

China expects US cooperation in new era

China-Europe +

China helps players from Europe tap potential

China-Africa +

Cooperation with Africa to remain deeply rooted

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349